NASDAQ:VRTX

Vertex Pharmaceuticals Stock News

etoro logo Buy VRTX
*Your capital is at risk
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Therapeutics (VRTX) enters into a licensing agreement with CRISPR for the latter's gene-editing technology to accelerate the development of its type I diabetes hypoimmune therapy programs.
While the enterprise software makers are in the doldrums, and the financial sector tries to recover from a battering, a few specialty software firms, including Intapp Inc. (NASDAQ: INTA), Vertex Inc.
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) is positioned to make a new run at the 52-week high of $325.19 as the stock is confirming a cup base pattern. The biotechnology company's stock is up 7.3% i
Two stocks that could make investors a lot of money are poised to benefit from the AI boom. One of the stocks is arguably more aligned with the U.S. economy's future than any other stock on the market
The Nasdaq Composite index has been down for over a year now, but some of its components are soaring. Vertex Pharmaceuticals is the only drugmaker selling lifesaving treatments for patients who inheri
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Vertex Pharmaceuticals' business is insulated from the effects of economic cycles. The biotech's history of innovation continues, and it's aiming to diversify its lineup.

The Best Stocks to Invest $20,000 in Right Now

05:50am, Tuesday, 21'st Mar 2023
Few tech giants are as attractively valued right now as Alphabet. Wall Street is especially bullish about Amazon -- and for good reason.
According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommen
If I were starting a new growth stock portfolio today, here are the stocks I'd buy.
Brookfield Renewable is poised to profit from an unstoppable trend. Dollar General should thrive even if the banking sector's troubles worsen.
Vertex Pharmaceuticals (VRTX) receives FDA clearance to begin clinical development of VX-264, which has the potential to treat type I diabetes.
Vertex's next launch could open the door to a multibillion-dollar opportunity. The company also has other treatment candidates, not to mention its flagship lineup.
CRISPR Therapeutics is a clinical-stage biotech company. The company's pipeline includes two promising wholly owned therapies.

2 No-Brainer Growth Stocks to Buy Right Now

05:57am, Wednesday, 08'th Mar 2023
Vertex Pharmaceuticals is a highly profitable and rapidly growing business with serious untapped potential. Airbnb benefits from multiple aspects of the travel economy, and that could give it remarkab
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE